| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,830 |
1,547 |
$114K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
912 |
818 |
$82K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,117 |
1,056 |
$20K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
238 |
223 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
95 |
89 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
359 |
292 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
39 |
39 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
40 |
40 |
$3K |
| 99177 |
|
232 |
222 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
28 |
26 |
$3K |
| 90686 |
|
626 |
575 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
87 |
85 |
$2K |
| 90656 |
|
102 |
102 |
$733.58 |
| 94760 |
|
447 |
379 |
$480.96 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$433.31 |
| 99072 |
|
16 |
13 |
$0.00 |
| 99000 |
|
132 |
125 |
$0.00 |
| 36416 |
|
29 |
26 |
$0.00 |